Equities

Aytu Biopharma Inc

Aytu Biopharma Inc

Actions
  • Price (EUR)1.94
  • Today's Change0.00 / 0.00%
  • Shares traded5.00
  • 1 Year change-30.22%
  • Beta--
Data delayed at least 15 minutes, as of Oct 31 2024 07:04 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue8110797
OPERATING EXPENSES
Cost of revenue total264144
Selling, general and admin. expenses, total497070
Depreciation/amortization5.214.795.84
Unusual expense(income)2.965.7175
Other operating expenses, total0(0.97)(1.66)
Total operating expense87124206
Operating income(5.85)(17)(110)
Other, net----1.61
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(14)(17)(109)
Provision for income taxes1.770(0.11)
Net income after taxes(16)(17)(109)
Minority interest------
Net income before extra. Items(16)(17)(109)
Total extraordinary items------
Net income(16)(17)(109)
Inc.avail. to common excl. extra. Items(16)(17)(109)
Inc.avail. to common incl. extra. Items(16)(17)(109)
EPS RECONCILIATION
Basic/primary weighted average shares5.543.341.47
Basic/primary eps excl. extra items(2.86)(5.11)(74)
Basic/primary eps incl. extra items(2.86)(5.11)(74)
Dilution adjustment------
Diluted weighted average shares5.543.341.47
Diluted eps excl. extra items(2.86)(5.11)(74)
Diluted eps incl. extra items(2.86)(5.11)(74)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental4.800.010.01
SUPPLEMENTAL INCOME
Depreciation, supplemental1.772.722.45
Total special items5.365.7175
NORMALISED INCOME
Normalized income before taxes(8.72)(11)(34)
Effect of special items on income taxes1.88026
Income tax excluding impact of special items3.64026
Normalized income after tax(12)(11)(60)
Normalized income avail. to common(12)(11)(60)
Basic normalized EPS(2.23)(3.4)(41)
Diluted normalized EPS(2.23)(3.4)(41)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.